drugset / Trial / NCT02266329

Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin

NCT02266329

Phase 1/2 Completed 89 enrolled VA Office of Research and Development
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if prazosin is more effective than placebo in decreasing frequency, severity, disability, and other negative effects of headaches related to mild traumatic brain injury in Service Members and Veterans.

Timeline

Start
2016-01-04
Primary completion
2023-05-31
Completion
2023-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prazosin Unknown 5 mg Oral
Comparator Prazosin Unknown 20 mg Oral